Peptide CAS Number, Formula & Molecular Weight Directory
Complete analytical cross-reference for all 66 research peptides, recombinant proteins, small-molecule probes, and sterile diluents supplied by SwissLab Peptides. Look up verified peptide CAS numbers (including Retatrutide, KPV, Copper Peptide GHK-Cu, GLOW blend, Tesamorelin, VIP, DSIP, and NAD+), molecular formulas, molar weights, and recommended reconstitution solvents.
| Compound | CAS Registry # | Formula | Molecular Weight | Primary Target / Pathway | Recommended Solvent | Registry |
|---|---|---|---|---|---|---|
| 5-Amino-1MQ 10 mg • ≥99.0% | 42464-96-0 | C10H11IN2 | 286.11 g/mol | Nicotinamide N-methyltransferase (NNMT) | Sterile DMSO (>25 mg/mL) or sterile aqueous buffer (~5 mg/mL) | CID 950107 ↗ |
| ACE-031 1 mg • ≥99.0% | 1169766-01-1 | Recombinant ActRIIB-IgG1-Fc Homodimer | ~79.0 kDa (homodimer) | Myostatin (GDF-8), GDF-11, and Activin A ligands | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4); avoid mechanical agitation | UniProt Q13705 ↗ |
| Acetic Acid Water 10 ml • USP Grade | 64-19-7 (0.6% v/v in USP Water) | CH3COOH (aq, 0.6% v/v) | 60.05 g/mol (acetic acid) | Acidic solubilization co-solvent for hydrophobic/basic peptides | Ready-to-use sterile liquid diluent (0.22 µm filtered) | CID 176 ↗ |
| Adipotide 5 mg • ≥99.0% | 859216-15-2 | C111H204N36O28S2 | 2555.20 g/mol | Prohibitin (PHB) on white adipose vasculature | Sterile 0.9% Bacteriostatic Water or sterile saline (0.9% NaCl) | CID 16139605 ↗ |
| AICAR 50 mg • ≥99.0% | 2627-69-2 | C9H14N4O5 | 258.23 g/mol | AMP-activated protein kinase (AMPK) | Sterile water (up to 15 mg/mL) or sterile DMSO (up to 50 mg/mL) | CID 17513 ↗ |
| AOD-9604 5 mg • ≥99.0% | 221231-10-3 | C78H123N23O23S2 | 1815.08 g/mol | β3-adrenergic lipolytic signaling pathways (non-IGF-1 axis) | Pre-solubilize in 0.1–0.2 mL sterile 0.6% Acetic Acid, then dilute with sterile Bacteriostatic Water | CID 71300630 ↗ |
| ARA 290 16 mg • ≥99.0% | 1208243-50-8 | C51H84N16O21 | 1257.31 g/mol | Innate Repair Receptor (EPOR / β-common receptor heteromer) | Sterile PBS (pH 7.4) or sterile 0.9% Bacteriostatic Water | CID 91810664 ↗ |
| B12 10 ml • ≥99.0% | 13422-55-4 | C63H91CoN13O14P | 1344.38 g/mol | Methionine synthase & cellular one-carbon methylation assays | Sterile aqueous preparation; protect strictly from UV/ambient light | CID 10898559 ↗ |
| Bacteriostatic Water 10 ml • USP Grade | 7732-18-5 (Water) / 100-51-6 (0.9% Benzyl Alcohol) | H2O + 0.9% C7H8O | 18.02 g/mol (water) / 108.14 g/mol (benzyl alcohol) | Multi-entry sterile diluent for lyophilized peptide reconstitution | Ready-to-use sterile liquid diluent (USP Type I glass vial) | CID 244 ↗ |
| BPC-157 5 mg • ≥99.2% | 137525-51-0 | C62H98N16O22 | 1419.53 g/mol | VEGFR2 / Akt-eNOS pathway, FAK-paxillin & growth hormone receptor expression | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4) up to 10 mg/mL | CID 9941957 ↗ |
| BPC-157 10mg + TB-500 10mg 10mg + 10mg • ≥99.0% | 137525-51-0 / 77591-33-4 | C62H98N16O22 + C212H350N56O78S | 1419.53 g/mol & 4963.50 g/mol | Dual VEGFR2/NO angiogenesis & G-actin sequestration pathways | Sterile 0.9% Bacteriostatic Water (2.0–3.0 mL); swirl gently without vortexing | CID 9941957 ↗ |
| BPC-157 5mg + TB-500 5mg 5mg + 5mg • ≥99.0% | 137525-51-0 / 77591-33-4 | C62H98N16O22 + C212H350N56O78S | 1419.53 g/mol & 4963.50 g/mol | Dual VEGFR2/NO angiogenesis & G-actin sequestration pathways | Sterile 0.9% Bacteriostatic Water (2.0 mL); dissolve gently by rolling | CID 9941957 ↗ |
| Cagrilintide + Semaglutide 2.5mg + 2.5mg • ≥99.0% | 1415456-99-3 / 910463-68-2 | C194H312N54O59S2 + C187H291N45O59 | 4409.04 g/mol & 4113.58 g/mol | Dual Amylin/Calcitonin (AMYR/CTR) + GLP-1R agonism | Sterile 0.9% Bacteriostatic Water or sterile neutral PBS buffer | CID 56843331 ↗ |
| Cagrilintide 5 mg • ≥99.0% | 1415456-99-3 | C194H312N54O59S2 | 4409.04 g/mol | Amylin receptors (AMY1R–AMY3R) & Calcitonin receptor (CTR) | Sterile 0.9% Bacteriostatic Water or sterile neutral saline; dissolve gently | CID 134818873 ↗ |
| Cerebrolysin 60 mg • ≥99.0% | 12656-61-0 | Low-MW Neuropeptide Fraction (<10 kDa) | <10,000 Da (peptide mixture) | Neurotrophic factor signaling (BDNF, NGF, GDNF, CNTF mimetics) | Sterile 0.9% Saline or Bacteriostatic Water | See spec |
| CJC-1295 (no DAC) 5 mg • ≥99.0% | 863288-34-0 | C152H252N44O42 | 3367.97 g/mol | Pituitary GHRH Receptor (Class B GPCR) | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | CID 56841945 ↗ |
| CJC-1295 5 mg • ≥99.0% | 863288-34-0 (with DAC) | C165H269N47O46 | 3647.28 g/mol | Pituitary GHRH Receptor + Covalent Serum Albumin (Cys34) Binding | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | CID 91976842 ↗ |
| CJC-1295 + Ipamorelin 5mg + 5mg • ≥99.0% | 863288-34-0 / 170851-70-4 | C152H252N44O42 + C38H49N9O5 | 3367.97 g/mol & 711.86 g/mol | Dual Pituitary GHRH-R & GHS-R1a (Ghrelin Receptor) | Sterile 0.9% Bacteriostatic Water (2.0 mL) | CID 9831659 ↗ |
| Custom Peptide Batch Custom (10mg–5g) • ≥99.0% | Sequence-Specific (Custom SPPS) | Per Client Sequence Specification | Calculated per Sequence (±0.1 Da ESI-MS) | Custom Institutional & Academic Assay Specification | Custom solubility profiling provided with batch CoA | See spec |
| DSIP 5 mg • ≥99.0% | 62568-57-4 | C35H48N10O15 | 848.81 g/mol | GABAergic / NMDA neuromodulatory & HPA-axis pathways | Sterile water, PBS (pH 7.4), or 0.9% Bacteriostatic Water (>10 mg/mL) | CID 68816 ↗ |
| Epitalon 10 mg • ≥99.0% | 307297-39-8 | C14H22N4O9 | 390.35 g/mol | Telomerase (hTERT) expression & pineal circadian gene transcription | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4) | CID 219042 ↗ |
| Follistatin 1 mg • ≥99.0% | 117628-82-7 | Recombinant 315-aa Glycoprotein (FS-344 isoform) | ~34.8 kDa (non-glycosylated core) | Activin A/B & Myostatin (GDF-8) extracellular antagonist | Pre-reconstitute gently in sterile 0.6% Acetic Acid or neutral sterile water with 0.1% BSA carrier; never vortex | UniProt P19883 ↗ |
| FOXO4-DRI 10 mg • ≥99.0% | 2460055-10-9 | C228H388N86O64 | 5358.13 g/mol | FOXO4–p53 protein–protein interaction (senolytic pathway) | Sterile PBS (pH 7.4) or sterile 0.9% Bacteriostatic Water | CID 155903284 ↗ |
| GHK-Cu 50 mg • ≥99.2% | 49557-75-7 | C14H24CuN6O4 | 403.93 g/mol | Extracellular matrix remodeling (Collagen I/III, Decorin, MMP/TIMP) & broad gene modulation | Sterile 0.9% Bacteriostatic Water or sterile saline (yields vivid clear blue solution) | CID 342538 ↗ |
| GHRP-2 5 mg • ≥99.0% | 158861-67-7 | C45H55N9O6 | 817.97 g/mol | Growth Hormone Secretagogue Receptor 1a (GHS-R1a) | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | CID 6918245 ↗ |
| GHRP-6 5 mg • ≥99.0% | 87616-84-0 | C46H56N12O6 | 873.01 g/mol | GHS-R1a (Ghrelin Receptor) & CD36 cytoprotective pathways | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | CID 5486806 ↗ |
| Glow Blend 70 mg (50/10/10) • ≥99.0% | 49557-75-7 / 137525-51-0 / 77591-33-4 | GHK-Cu (50mg) + BPC-157 (10mg) + TB-500 (10mg) | 403.93 / 1419.53 / 4963.50 g/mol | Extracellular matrix remodeling, VEGFR2 angiogenesis & G-actin motility | Sterile 0.9% Bacteriostatic Water (3.0 mL); gently swirl to clear blue solution | CID 342538 ↗ |
| Glutathione 1500 mg • ≥99.0% | 70-18-8 | C10H17N3O6S | 307.32 g/mol | Glutathione Peroxidase / Reductase intracellular redox system | Deoxygenated sterile water or mildly acidic sterile saline (pH 5.0–6.0) | CID 124886 ↗ |
| Gonadorelin 10 mg • ≥99.0% | 33515-09-2 | C55H75N17O13 | 1182.29 g/mol | Pituitary Gonadotropin-Releasing Hormone Receptor (GnRHR) | Sterile 0.9% Bacteriostatic Water or sterile 0.9% saline | CID 638793 ↗ |
| HCG 5000 IU • ≥99.0% | 9002-61-3 | Heterodimeric Glycoprotein (α + β subunits) | ~36.7 kDa (glycosylated heterodimer) | Luteinizing Hormone / Choriogonadotropin Receptor (LHCGR) | Sterile 0.9% Bacteriostatic Water (2.0–5.0 mL); roll gently, never shake | UniProt P01233 ↗ |
| Hexarelin 5 mg • ≥99.0% | 140703-51-1 | C47H58N12O6 | 887.04 g/mol | GHS-R1a (Ghrelin Receptor) & Cardiac CD36 Receptor | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | CID 6918297 ↗ |
| HGH 10 IU (3.33 mg) • ≥99.0% | 12629-01-5 | C990H1529N263O299S7 | 22,124 Da (191-aa polypeptide) | Growth Hormone Receptor (GHR) / JAK2–STAT5 signaling | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL); trickle down glass wall, NEVER shake | UniProt P01241 ↗ |
| HMG 75 IU • ≥99.0% | 61489-71-2 | Purified FSH + LH Glycoprotein Complex (1:1 IU) | ~30–35 kDa (FSH & LH heterodimers) | FSHR (Follicle-Stimulating) & LHCGR Receptors | Sterile 0.9% saline or Bacteriostatic Water (1.0 mL); swirl gently | UniProt P01225 ↗ |
| IGF-1 LR3 1 mg • ≥99.0% | 946870-92-4 | C400H625N111O115S9 | 9111.50 g/mol | Insulin-like Growth Factor 1 Receptor (IGF-1R) with reduced IGFBP binding | Pre-dissolve in sterile 0.6% (10 mM) Acetic Acid (0.5–1.0 mL), then dilute with buffered carrier solution | UniProt P05019 ↗ |
| Ipamorelin 5 mg • ≥99.2% | 170851-70-4 | C38H49N9O5 | 711.85 g/mol | Selective Growth Hormone Secretagogue Receptor 1a (GHS-R1a) | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | CID 9831659 ↗ |
| Kisspeptin 5 mg • ≥99.0% | 374675-21-5 | C63H83N17O14 | 1302.44 g/mol | KISS1R (GPR54) hypothalamic GPCR | Sterile 0.9% Bacteriostatic Water or sterile PBS (or minimal DMSO pre-solubilization) | CID 25240297 ↗ |
| Klow 80 mg (50/10/10/10) • ≥99.0% | 49557-75-7 / 137525-51-0 / 77591-33-4 / 67727-97-3 | GHK-Cu (50mg) + BPC-157 (10mg) + TB-500 (10mg) + KPV (10mg) | 403.93 / 1419.53 / 4963.50 / 342.43 g/mol | ECM remodeling, angiogenesis, G-actin motility & NF-κB anti-inflammatory signaling | Sterile 0.9% Bacteriostatic Water (3.0–4.0 mL); gently swirl until clear blue | CID 342538 ↗ |
| KPV 10 mg • ≥99.0% | 67727-97-3 | C16H30N4O4 | 342.43 g/mol | NF-κB nuclear translocation & PepT1-mediated mucosal inflammatory pathways | Sterile 0.9% Bacteriostatic Water or sterile PBS (>20 mg/mL) | CID 125672 ↗ |
| L-carnitine 500 mg/ml (10 ml) • ≥99.0% | 541-15-1 | C7H15NO3 | 161.20 g/mol | Carnitine Palmitoyltransferase I/II (CPT1/CPT2) mitochondrial fatty acid shuttle | Ready-to-use sterile aqueous preparation | CID 10917 ↗ |
| Lemon Bottle 10 ml • ≥99.0% | 83-88-5 / 8002-43-5 / 9001-00-7 | Riboflavin + Lecithin + Bromelain Complex | Multi-component enzymatic solution | Adipocyte lipid-emulsification & enzymatic proteolysis models | Ready-to-use sterile 10 ml research vial | CID 493570 ↗ |
| Lipo-C 10 ml • ≥99.0% | 63-68-3 / 87-89-8 / 67-48-1 | Methionine + Inositol + Choline (MIC) + B-Complex | Multi-cofactor lipotropic solution | Hepatic one-carbon methylation & VLDL phospholipid export pathways | Ready-to-use sterile 10 ml liquid vial | CID 6137 ↗ |
| LL-37 5 mg • ≥99.0% | 154947-66-7 | C205H340N60O53 | 4493.26 g/mol | Antimicrobial membrane disruption, FPR2 chemotaxis & biofilm inhibition | Sterile water or 0.9% Bacteriostatic Water; avoid high-salt precipitation at concentrated stocks | CID 16198951 ↗ |
| Mazdutide 5 mg • ≥99.0% | 2259884-03-0 | C210H322N46O67 | 4563.06 g/mol | Dual GLP-1 Receptor (GLP-1R) & Glucagon Receptor (GCGR) Agonist | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4) | CID 156588324 ↗ |
| Melanotan I 10 mg • ≥99.0% | 75921-69-6 | C78H111N21O19 | 1646.85 g/mol | Selective Melanocortin-1 Receptor (MC1R) Agonist | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | CID 16132283 ↗ |
| Melanotan II 10 mg • ≥99.0% | 121062-08-6 | C50H69N15O9 | 1024.18 g/mol | Pan-Melanocortin Receptors (MC1R, MC3R, MC4R, MC5R) | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | CID 92432 ↗ |
| Melatonin 10 mg • ≥99.0% | 73-31-4 | C13H16N2O2 | 232.28 g/mol | MT1 (MTNR1A) & MT2 (MTNR1B) Melatonin GPCRs & Mitochondrial Free-Radical Scavenging | Sterile ethanol or DMSO stock (>50 mg/mL), diluted into aqueous buffer | CID 896 ↗ |
| MOTS-c 10 mg • ≥99.0% | 1627580-64-6 | C101H152N28O22S2 | 2174.62 g/mol | Folate-AICAR-AMPK pathway & mitochondrial-nuclear stress signaling | Sterile 0.9% Bacteriostatic Water or neutral PBS (1.0–2.0 mL); minimize air agitation | CID 145994650 ↗ |
| NAD+ 500 mg • ≥99.2% | 53-84-9 | C21H27N7O14P2 | 663.43 g/mol | Sirtuins (SIRT1–SIRT7), PARPs, CD38 & Mitochondrial Complex I | Sterile PBS (pH 6.0–7.0) or Bacteriostatic Water (adjust pH carefully for cell assays) | CID 5893 ↗ |
| Oxytocin 5 mg • ≥99.0% | 50-56-6 | C43H66N12O12S2 | 1007.19 g/mol | Oxytocin Receptor (OXTR, Gq-coupled GPCR) | Sterile 0.9% Bacteriostatic Water or sterile saline (pH 4.5–6.5) | CID 439302 ↗ |
| PEG-MGF 2 mg • ≥99.0% | 108174-48-7 (MGF core, PEGylated) | mPEG(20kDa)-IGF-1Ec(24-aa) Conjugate | ~22.9 kDa (2868 Da peptide + 20 kDa mPEG) | Satellite cell activation & localized mechanical-stress myogenesis | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4); dissolve gently | UniProt P05019 ↗ |
| PT-141 10 mg • ≥99.0% | 189691-06-3 | C50H68N14O10 | 1025.16 g/mol | Central Melanocortin-4 (MC4R) & MC3R Receptors | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | CID 9941379 ↗ |
| Retatrutide 10 mg • ≥99.2% | 2381089-83-2 | C221H342N46O68 | 4731.33 g/mol | Triple GIP Receptor (GIPR), GLP-1R & Glucagon Receptor (GCGR) Agonist | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4); swirl gently | CID 171390338 ↗ |
| Selank 5 mg • ≥99.0% | 129954-34-3 | C33H57N11O9 | 751.87 g/mol | GABA-A allosteric modulation, enkephalinase inhibition & IL-6/BDNF gene expression | Sterile 0.9% Bacteriostatic Water or sterile saline (>10 mg/mL) | CID 11765600 ↗ |
| Semaglutide 5 mg • ≥99.2% | 910463-68-2 | C187H291N45O59 | 4113.58 g/mol | Selective Glucagon-Like Peptide-1 Receptor (GLP-1R) Agonist | Sterile 0.9% Bacteriostatic Water or sterile neutral PBS (pH 7.4) | CID 56843331 ↗ |
| Semax 5 mg • ≥99.0% | 80714-61-0 | C37H51N9O10S | 813.92 g/mol | BDNF / TrkB & NGF neurotrophin expression, dopaminergic/serotonergic modulation | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4) | CID 122178 ↗ |
| Sermorelin 5 mg • ≥99.0% | 86168-78-7 | C149H246N44O42S | 3357.88 g/mol | Pituitary GHRH Receptor (native short-acting reference ligand) | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | CID 16129620 ↗ |
| SLU-PP-332 5 mg • ≥99.0% | 303760-60-3 | C18H14N2O2 | 290.32 g/mol | Estrogen-Related Receptors ERRα (EC50 98 nM), ERRβ & ERRγ | Sterile DMSO (up to 20–30 mg/mL); insoluble in pure water | CID 5338394 ↗ |
| SNAP-8 10 mg • ≥99.0% | 868844-74-0 | C41H70N16O16S | 1075.16 g/mol | SNARE / SNAP-25 complex vesicle docking inhibition | Sterile water, PBS (pH 7.4), or cosmetic formulation aqueous phase | CID 16131222 ↗ |
| SS-31 10 mg • ≥99.0% | 736992-21-2 | C32H49N9O5 | 639.79 g/mol | Inner mitochondrial membrane Cardiolipin & Electron Transport Chain supercomplexes | Sterile 0.9% Bacteriostatic Water or sterile PBS (>10 mg/mL) | CID 11764719 ↗ |
| Survodutide 5 mg • ≥99.0% | 2805997-46-8 | C192H289N47O61 | 4231.65 g/mol | Dual Glucagon Receptor (GCGR) & GLP-1 Receptor (GLP-1R) Agonist | Sterile 0.9% Bacteriostatic Water or sterile neutral PBS (pH 7.4) | CID 168311919 ↗ |
| TB-500 10 mg • ≥99.0% | 77591-33-4 | C212H350N56O78S | 4963.50 g/mol | Monomeric G-Actin sequestration, cell motility & angiogenesis | Sterile 0.9% Bacteriostatic Water (2.0 mL); gently roll vial, do not vortex | CID 16132341 ↗ |
| Tesamorelin 5 mg • ≥99.0% | 218949-48-5 | C221H366N72O67S | 5135.77 g/mol | Pituitary GHRH Receptor (full-length stabilized GHRH 1-44 analogue) | Sterile 0.9% Bacteriostatic Water (1.0–2.0 mL) | CID 16137828 ↗ |
| Thymalin 10 mg • ≥99.0% | 69558-55-0 (Thymogen / Glu-Trp active core) | C16H19N3O5 (Glu-Trp dipeptide core) | 333.34 g/mol (core dipeptide) | T-lymphocyte differentiation & thymic immune homeostasis models | Sterile 0.9% saline or Bacteriostatic Water (1.0–2.0 mL) | CID 155830 ↗ |
| Thymosin Alpha-1 5 mg • ≥99.0% | 62304-98-7 | C129H215N33O55 | 3108.28 g/mol | TLR2 / TLR9 dendritic cell maturation & Th1 cytokine signaling | Sterile PBS (pH 7.4) or sterile 0.9% Bacteriostatic Water (acidic peptide; dissolves readily at neutral pH) | CID 16130571 ↗ |
| Tirzepatide 10 mg • ≥99.2% | 2023788-19-2 | C225H348N48O68 | 4813.45 g/mol | Dual GIP Receptor (GIPR) & GLP-1 Receptor (GLP-1R) Co-Agonist | Sterile 0.9% Bacteriostatic Water or sterile PBS (pH 7.4) | CID 156588324 ↗ |
| VIP 5 mg • ≥99.0% | 40077-57-4 | C147H238N44O42S | 3325.80 g/mol | VPAC1 & VPAC2 (Class B GPCRs) — neuroimmune & circadian signaling | Sterile 0.9% Bacteriostatic Water or neutral PBS (pH 7.0–7.4) | CID 16132391 ↗ |
CAS vs. Counterion Mass
Published molecular weights reflect free-base or designated salt forms (e.g., iodide salt for 5-Amino-1MQ). For precise molarity in cellular assays, apply batch Net Peptide Content (NPC) in our Molarity Calculator.
Orthogonal Protein vs. Peptide Verification
Synthetic peptides (<6 kDa) are qualified via RP-HPLC & ESI-MS, whereas recombinant proteins (ACE-031, rhGH, Follistatin, hCG, hMG) are evaluated via SEC-HPLC & SDS-PAGE. Inspect all active lot methods in our Batch COA Registry.
Solvent & Isoelectric Point (pI)
Neutral sequences dissolve in USP 0.9% Benzyl Alcohol Bacteriostatic Water; hydrophobic polypeptides (IGF-1 LR3, AOD-9604) require initial 0.6% Acetic Acid dissolution. Review full protocols in the Reconstitution SOP.